Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.76%

Investing.com – Denmark stocks were higher after the close on Thursday, as gains in the , and sectors led shares higher.

At the close in Copenhagen, the added 0.76%.

The best performers of the session on the were Genmab (CSE:), which rose 3.31% or 48.5 points to trade at 1515.0 at the close. Meanwhile, Chr. Hansen Holding A/S (CSE:) added 2.27% or 11.6 points to end at 522.0 and Danske Bank A/S (CSE:) was up 1.89% or 2.0 points to 110.3 in late trade.

The worst performers of the session were Novozymes A/S B (CSE:), which fell 2.01% or 6.5 points to trade at 316.2 at the close. Coloplast A/S (CSE:) declined 0.61% or 5.0 points to end at 815.0 and Vestas Wind Systems A/S (CSE:) was down 0.59% or 3.8 points to 641.6.

Rising stocks outnumbered declining ones on the Copenhagen Stock Exchange by 92 to 44 and 18 ended unchanged.

Crude oil for February delivery was down 0.34% or 0.20 to $59.41 a barrel. Elsewhere in commodities trading, Brent oil for delivery in March fell 0.09% or 0.06 to hit $65.38 a barrel, while the February Gold Futures contract fell 0.45% or 7.05 to trade at $1553.15 a troy ounce.

USD/DKK was down 0.04% to 6.7259, while EUR/DKK rose 0.03% to 7.4732.

The US Dollar Index Futures was up 0.13% at 97.125.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.